Generex Biotechnology Announces Satisfaction of Debt Obligation

    NEXT STORY
    ImCheck Therapeutics appoints Paul Frohna MD, PhD, PharmD,as Chief Medical Officer
    PREV STORY
    Alimera Sciences Announces the Appointment of Industry Veteran and Ophthalmology Business Executive John Snisarenko to its Board of Directors
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Melinta Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

    author_avatar
    NASDAQ Market News

    NewLink Genetics Announces Clinical Collaboration to Evaluate IO-Based Combination Therapies in Pancreatic Cancer

    AMES, Iowa, Sept. 25, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced ...

    author_avatar
    NASDAQ Market News

    Oncobiologics, Inc. to Present at the 2016 Cantor Fitzgerald 2nd Annual Healthcare Conference

    CRANBURY, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...

    author_avatar
    NASDAQ Market News